EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adicon Holdings's enterprise value is HK$6,052 Mil.
Adicon Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$706 Mil. Therefore, Adicon Holdings's EV-to-EBITDA for today is 8.58.
The historical rank and industry rank for Adicon Holdings's EV-to-EBITDA or its related term are showing as below:
HKSE:09860'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.88 Med: 9.05 Max: 14.02
Current: 8.76
During the past 4 years, the highest EV-to-EBITDA of Adicon Holdings was 14.02. The lowest was 5.88. And the median was 9.05.
HKSE:09860's EV-to-EBITDA is ranked better than 74.34% of 113
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.37
vs HKSE:09860: 8.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Adicon Holdings EV-to-EBITDA Historical Data
The historical data trend for Adicon Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Adicon Holdings's EV-to-EBITDA
For the Diagnostics & Research subindustry, Adicon Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's EV-to-EBITDA falls into.
Adicon Holdings's current Enterprise Value is HK$6,052 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adicon Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$706 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Adicon Holdings's PE Ratio for today is calculated as:
Adicon Holdings's share price for today is HK$8.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adicon Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.339.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Adicon Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09860 has been successfully added to your